A prospective, open-label trial of ondansetron in adolescents with alcohol dependence
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier in Addictive Behaviors
- Vol. 30 (6) , 1077-1085
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- PHARMACOTHERAPEUTIC TRIALS IN ADOLESCENT ALCOHOL USE DISORDERS: OPPORTUNITIES AND CHALLENGESAlcohol and Alcoholism, 2004
- Four-year outcomes from adolescent alcohol and drug treatment.Journal of Studies on Alcohol, 2001
- An Overview of Controlled Studies of Adolescent Substance Abuse TreatmentThe American Journal on Addictions, 2001
- Ondansetron for Reduction of Drinking Among Biologically Predisposed Alcoholic PatientsJAMA, 2000
- Neuropharmacological treatments for alcoholism: scientific basis and clinical findingsPsychopharmacology, 2000
- A review of central 5-HT receptors and their functionNeuropharmacology, 1999
- Alcohol‐induced reinforcement: Dopamine and 5‐HT3 receptor interactions in animals and humansDrug Development Research, 1993
- Effect of 5‐HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the ratBritish Journal of Pharmacology, 1990
- Laterality of dopamine function and neuroleptic action in the amygdala in the ratNeuropharmacology, 1985
- Early predictors of age at first use of alcohol, marijuana, and cigarettesDrug and Alcohol Dependence, 1982